C-reactive protein, inflammation, and innate immunity

Immunologic Research

Volumn 24, Issue 2, 2001, Pages 163-176

  Mortensen, R F ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Acute Phase Proteins; Atheriosclerosis; C Reactive Protein; Innate Immunity; Monocytes; Neutrophils; Phagocytosis

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; CYTOKINE; ESTER; FC RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; ORGANOPHOSPHATE; TRANSCRIPTION FACTOR;

ARTICLE; ATHEROSCLEROSIS; COMPLEMENT ACTIVATION; CORONARY ARTERY DISEASE; CYTOKINE RELEASE; GENE EXPRESSION; HOST RESISTANCE; HUMAN; IMMUNITY; INFLAMMATION; LIVER CELL; MICROBIAL IMMUNITY; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE;

C-REACTIVE PROTEIN; COMPLEMENT ACTIVATION; CORONARY ARTERIOSCLEROSIS; IMMUNITY, NATURAL; INFLAMMATION; MODELS, MOLECULAR; PHAGOCYTOSIS; RECEPTORS, IMMUNOLOGIC;

EID: 0034822711     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:24:2:163     Document Type: Article

References (121)

1. The instructive role of innate immunity in the acquired immune response
2. Innate immunity
3. Phylogenetic perspectives in innate immunity
4. Acute-phase proteins and other systemic responses to inflammation
5. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A component
6. Initiation of the acute phase response and synthesis of cytokines
7. C-reactive protein and the acute phase response
8. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus
9. The occurrence during acute infections of a protein not normally present in the blood. I. Distribution of the reactive protein in patient's sera and the effect of calcium on the flocculation reaction with C-polysaccharide of pneumococcus
10. Historical perspective on C-reactive protein
11. Function of C-reactive protein
12. Structure and function of the Pentraxins
13. Regulation of phagocytic leukocyte activities by C-reactive protein
14. The major receptor for C-reactive protein on leukocytes is Fcγ-receptor II
15. C-reactive protein binding to murine leukocytes requires Fcγ-receptors
16. C-reactive protein binding to FcγRIIa on human monocytes and neutrophils is allele-specific
17. C-reactive protein, inflammation, and coronary risk
18. Atherosclerosis - An inflammatory disease
19. C-reactive protein structural biology, gene expression, and host defense function
20. C-reactive protein: Structural biology and host defense function
21. Three dimensional structure of human C-reactive protein
22. The physiological structure of human C-reactive protein and its complex with phosphocholine
23. Acute phase proteins with special reference to C-reactive protein and related proteins (pentraxins) and serum amyloid A protein
24. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure
25. IL-1 and IL-6 mediate increased production and synthesis of the acute phase reactant mouse serum amyloid P-component (SAP)
26. Cloning and tissue specific expression of the gene for mouse C-reactive protein
27. Characterization of genomic and complementary DNA sequence of human C-reactive protein and comparison with the complementary DNA sequence of serum amyloid P component
28. Fine mapping of the human pentraxin gene region on chromosome 1q23
29. Structure of pentameric human serum amyloid P component
30. Comparative analysis of pentraxins: Implications for protomer assembly and ligand binding
31. Topology and structure of the C1q-binding site on C-reactive protein
32. Site-directed mutagenesis of the phosphocholine-binding site of human C-reactive protein
33. Kinetic modeling and mathematical analysis indicate that acute phase gene expression in Hep3B cells is regulated by both transcriptional and posttranscriptional mechanisms
34. Regulation of human C-reactive protein gene expression by two synergistic IL-6 responsive elements
35. The effect of IL-1 on C-reactive protein expression in Hep3B cells is exerted at the transcriptional level
36. STAT3 participates in transcriptional activation of the C-reactive protein gene by IL-6
37. Interleukin-6 is necessary, but not sufficient for induction of the human C-reactive gene in vivo
38. C-reactive protein and serum amyloid A mRNA stability following induction by cytokines
39. The Rel family member P50 mediates cytokine-induced C-reactive protein expression by a novel mechanism
40. Transactivation of C-reactive protein by IL-6 requires synergistic interaction of CCAAT/enhancer binding protein β (C/EBPβ) and Relp50
41. Identification of a C-reactive protein binding site in two hepatic carboxylesterases capable of retaining C-reactive protein within the endoplasmic reticulum
42. The role of C/EBP isoforms in the control of inflammatory and native immunity functions
43. Role of STAT3 and C/EBP in cytokine-dependent expression of the mouse serum amyloid P-component (SAP) and C-reactive protein (CRP) genes
44. Comparison of protein structure and genomic structure of human, rabbit and Limulus C-reactive proteins: Possible implications for function and evolution
45. Acute phase proteins in salmonids
46. C-reactive protein and SAP-like pentraxins are both present in Limulus polyphemus Haemolymph: Crystal structure of Limulus SAP
47. Semantics, inflammation, cytokines and common sense
48. Regulation of the human C-reactive protein gene in transgenic mice
49. Expression of rabbit C-reactive protein in transgenic mice
50. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice
51. Transgenic mice expressing rabbit C-reactive protein (CRP) are resistant to endotoxemia
52. Inhibition of C5a des-Arg induced neutrophil alveolitis in transgenic mice expressing C-reactive protein
53. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers
54. C-reactive protein: Binding to lipids and lipoproteins
55. Pentraxin family of proteins interact specifically with phosphorylcholine and/or phosphoethanolamine
56. Binding of human serum amyloid P-component to phosphorylcholine
57. Binding of C-reactive protein to chromatin and nucleosome core particles. A possible physiological role of C-reactive protein
58. The interaction of C-reactive protein and serum amyloid P component with nuclear antigens
59. Interaction of very low density lipoprotein (VLDL) with rabbit C-reactive protein
60. Binding of model soluble immune complexes to modified C-reactive protein
61. Characteristics of the binding of human C-reactive protein (CRP) to laminin
62. Regulation of complement activation by C-reactive protein
63. Regulation of complement activation by C-reactive protein: Targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11
64. C-reactive protein binds to apoptic cells, protects the cells from assembly of the terminal complement components, and sustains an anti-inflammatory innate immune response: Implications for systemic autoimmunity
65. CRP-mediated activation of complement in vivo. Assessment by measuring circulating complement-C-reactive protein complexes
66. Complement-dependent acute phase expression of C-reactive protein and serum amyloid P-component
67. Testerone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice
68. Mouse C-reactive protein and endotoxin-induced resistance
69. Association of C-reactive protein and circulating leukocytes with resistance to Staphylococcus aureus infection in endotoxin-treated mice and rabbits
70. C-reactive protein - A phagocytosis promoting factor
71. Interactions of C-reactive protein with lymphocytes and monocytes: Complement dependent adherence and phagocytosis
72. Mediation of CRP-dependent phagocytosis through mouse macrophage Fc-receptors
73. C-reactive protein is protective against Streptococcus pneumoniae infection in mice
74. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice
75. The role of complement in C-reactive protein mediated protection of mice from Streptococcus pneumoniae
76. The position of phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae affects binding sensitivity to C-reactive protein-mediated killing
77. Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice
78. C-reactive protein binds to a novel ligand on Leishmania donovani and increases uptake into human macrophages
79. Opsonic effect of C-reactive protein on phagocytosis and intracellular killing of virulent and attenuated strains of Candida albicans by human neutrophils
80. Inhibition of C5a des-Arg induced neutrophil alveolitis in transgenic mice expressing C-reactive protein
81. Inflammatory potential of C-reactive protein complexes compared to immune complexes
82. C-Reactive Protein: A physiological activator of interleukin 6 receptor shedding
83. Prevention of in vitro neutrophil adhesion to endothelial cell through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein
84. Effect of human C-reactive protein on chemokine and chemotactic factor-induced neutrophil chemotaxis and signaling
85. Modulation of human neutrophil function by C-reactive protein
86. Effects of C-reactive protein on human neutrophil granulocytes challenged with N-formyl-methionyl-leucylphenylalanine and platelet-activating factor
87. Binding of C-reactive protein to human neutrophils. Inhibition of respiratory burst
88. The regulation of superoxide generation and nitric oxide synthesis by C-reactive protein
89. Assembly of the phagocyte NADPH oxidase: Molecular interaction of the oxidase proteins
90. Complement regulation in innate immunity and the acute-phase response: Inhibition of mannan-binding lectin-initiated complement cytolysis by C-reactive protein
91. Acute phase levels of C-reactive protein enhance IL- 1β and IL-1ra production by human blood monocytes but inhibit IL-1β and IL-1ra production by alveolar macrophages
92. C-reactive protein is involved in natural killer cell-mediated lysis but does not mediate effector-target cell recognition
93. Macrophagetumoricidal activity induced by C-reactive protein
94. Activation of human monocyte tumoricidal activity by C-reactive protein
95. Binding of human C-reactive protein to mouse macrophages is mediated by distinct receptors
96. Characterization and isolation of a C-reactive protein receptor from the human monocytic cell line U-937
97. C-reactive protein receptors on the human monocytic cell line U937. Evidence for additional binding to FcγRI
98. 2 intermediates
99. Binding sites for C-reactive protein on human monocytes are distinct from IgG Fc receptors
100. C-reactive protein binds to FcγRI in transfected COS cells
101. Monoclonal antibody to the type II Fc receptor for human IgG blocks potentiation of monocyte and neutrophil IgGinduced respiratory burst activation by C-reactive protein
102. Molecular Basis of Fc Receptor Function
103. Serum amyloid P component binds to Fcγ receptors and opsonizes particles for phagocytosis
104. Fc Receptor Biology
105. Immune inhibitory receptors
106. Signalling via leukocyte CRP-receptor: PI-3-kinase is involved in the inhibition of the fMLP activaried responses
107. The relationship between the acute phase response and antibody production in the rabbit. I. Correlation between the early appearance of Cx-reactive protein and subsequent antibody production
108. The role of inflammation in vascular diseases
109. Association of fibrinogen, C-reactive protein, albumin, leukocyte count with coronary heart disease. Meta analyses of prospective studies
110. C-reactive protein as a predictor of cardiac rupture after acute myocardial infarction
111. Low-grade inflammation and coronary heart disease: New prospective studies and updated meta-analysis
112. C-reactive protein as a cardiovascular risk factor. More than an epiphenomenon?
113. Immunohistochemical studies of C-reactive protein and apolipoprorein B in inflammatory and arterial lesions
114. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction
115. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries
116. C-reactive protein in the arterial intima: Role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis
117. Low density lipoprotein and very low density lipoprorein are selectively bound by aggregated C-reactive protein
118. Inflammation-induced changes in rabbit CRP and plasma lipoproteins
119. Modulation of human monocyte chemotaxis and procoagulant activity by human C-reactive protein
120. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
121. Association of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly